Report cover image

Transfection Technologies Market

Publisher IMARC Services Pvt. Ltd.
Published Apr 01, 2026
Length 142 Pages
SKU # IMRC21082051

Description

The global transfection technologies market size was valued at USD 1,348.6 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,431.3 Million by 2034, exhibiting a CAGR of 6.56% from 2026-2034. North America currently dominates the market, holding a market share of 39.3% in 2025. The transfection technologies market share is growing because of strong research infrastructure, high healthcare spending, widespread adoption of advanced genomic tools, significant biotech and pharma presence, and supportive government funding for genetic research and drug discovery.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global transfection technologies market report, along with forecasts at the global, regional and country level from 2026-2034. The report has categorized the market based on product type, application, transfection method, technology and end-user.

Breakup by Product Type
  • Reagent
  • Instrument
  • Others
Breakup by Application
  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others
Breakup by Transfection Method
  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others
Breakup by Technology
  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection
Breakup by End-User
  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others
Breakup by Region
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. What was the size of the global transfection technologies market in 2025?

2. What is the expected growth rate of the global transfection technologies market during 2026-2034?

3. What are the key factors driving the global transfection technologies market?

4. What has been the impact of COVID-19 on the global transfection technologies market?

5. What is the breakup of the global transfection technologies market based on the product type?

6. What is the breakup of the global transfection technologies market based on the application?

7. What is the breakup of the global transfection technologies market based on the transfection method?

8. What is the breakup of the global transfection technologies market based on the technology?

9. What are the key regions in the global transfection technologies market?

10. Who are the key players/companies in the global transfection technologies market?10. Who are the key players/companies in the global transfection technologies market?

Table of Contents

142 Pages
1   Preface
2   Scope and Methodology
2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
4.1    Overview
4.2    Key Industry Trends
5   Global Transfection Technologies Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6   Market Breakup by Product Type
6.1    Reagent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2    Instrument
6.2.1 Market Trends
6.2.2 Market Forecast
6.3    Others
6.3.1 Market Trends
6.3.2 Market Forecast
7   Market Breakup by Application
7.1    Therapeutic Delivery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Bio-Medical Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3    Protein Production
7.3.1 Market Trends
7.3.2 Market Forecast
7.4    Others
7.4.1 Market Trends
7.4.2 Market Forecast
8   Market Breakup by Transfection Method
8.1    Lipofection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Eletroporation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3    Nucleofection
8.3.1 Market Trends
8.3.2 Market Forecast
8.4    Cotransfection
8.4.1 Market Trends
8.4.2 Market Forecast
8.5    Cationic Lipid Transfection
8.5.1 Market Trends
8.5.2 Market Forecast
8.6    In-Vivo Transfection
8.6.1 Market Trends
8.6.2 Market Forecast
8.7    Others
8.7.1 Market Trends
8.7.2 Market Forecast
9   Market Breakup by Technology
9.1    Physical Transfection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Biochemical Based Transfection
9.2.1 Market Trends
9.2.2 Market Forecast
9.3    Viral-Vector Based Transfection
9.3.1 Market Trends
9.3.2 Market Forecast
10  Market Breakup by End-User
10.1    Research Centers and Academic Institutes
10.1.1 Market Trends
10.1.2 Market Forecast
10.2    Hospitals and Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3    Pharmaceutical and Biotechnology Companies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4    Others
10.4.1 Market Trends
10.4.2 Market Forecast
11  Market Breakup by Region
11.1    North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2    Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3    Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4    Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5    Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12  SWOT Analysis
12.1    Overview
12.2    Strengths
12.3    Weaknesses
12.4    Opportunities
12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis
14.1    Overview
14.2    Bargaining Power of Buyers
14.3    Bargaining Power of Suppliers
14.4    Degree of Competition
14.5    Threat of New Entrants
14.6    Threat of Substitutes
15  Competitive Landscape
15.1    Market Structure
15.2    Key Players
15.3    Profiles of Key Players
15.3.1    Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2    Altogen Biosystems
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3    Amsbio
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4    Bio-RAD Laboratories Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5    Lonza Group AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6    Maxcyte Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7    Mirus Bio LLC
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8    Promega Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9    QIAGEN N.V.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10    Sartorius AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11    SignaGen Laboratories
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12    Takara Bio Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13    Thermo Fisher Scientific Inc.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us